Last 12 months
Inside the activity.
0 purchase rows · 143 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 34 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 92 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 23, 2012 Filed May 25, 2012 21:38 UTC |
Chai NelsonDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-018321 · form4.xml · nonDerivative · entry 1 Chai Nelson · CIK 0001299914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Read SEC document |
| May 23, 2012 Filed May 25, 2012 23:16 UTC |
SPERLING SCOTT MDirector
|
GrantCommon Stock | 2,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-009201 · edgar.xml · nonDerivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,314 Read SEC document |
| May 09, 2012 Filed May 10, 2012 20:44 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 26,400 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-016477 · form4.xml · derivative · entry 3 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 26,400 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| May 09, 2012 Filed May 10, 2012 20:44 UTC |
Malus Alan JExecutive Vice President
|
SaleCommon Stock | 26,400 | $53.36 | $1,408,704.00 |
DisclosureSEC source: 0001127602-12-016477 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,899 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.32 to $53.39, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2012 Filed May 10, 2012 20:44 UTC |
Malus Alan JExecutive Vice President
|
Exercise / conversionCommon Stock | 26,400 | $43.37 | $1,144,968.00 |
DisclosureSEC source: 0001127602-12-016477 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2012 Filed May 1, 2012 19:31 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001127602-12-015166 · form4.xml · derivative · entry 3 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2012-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on May 17, 2006, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc. Read SEC document |
| April 30, 2012 Filed May 1, 2012 19:31 UTC |
ULLIAN ELAINEDirector
|
SaleCommon Stock | 7,500 | $55.22 | $414,150.00 |
DisclosureSEC source: 0001127602-12-015166 · form4.xml · nonDerivative · entry 2 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,657 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.21 to $55.23, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 30, 2012 Filed May 1, 2012 19:31 UTC |
ULLIAN ELAINEDirector
|
Exercise / conversionCommon Stock | 7,500 | $26.53 | $198,975.00 |
DisclosureSEC source: 0001127602-12-015166 · form4.xml · nonDerivative · entry 1 ULLIAN ELAINE · CIK 0001190290 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2012 Filed Apr 3, 2012 18:12 UTC |
SPERLING SCOTT MDirector
|
GrantPhantom Stock Units · Derivative | 399.08 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-12-018799 · doc1.xml · derivative · entry 1 SPERLING SCOTT M · CIK 0001214212 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,889.86 Underlying: Common Stock · 399.08 shares Expires not disclosed F1 · derivative.exercise_price: Convertible into Common Stock on a 1-for-1 basis. F2 · price: Represents stock units credited to the Reporting Person's account as of March 31, 2012, at a price of $56.38 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.exercise_date: Represents stock units credited to the Reporting Person's account as of March 31, 2012, at a price of $56.38 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. F2 · derivative.expiration_date: Represents stock units credited to the Reporting Person's account as of March 31, 2012, at a price of $56.38 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. Read SEC document |
| March 19, 2012 Filed Mar 20, 2012 21:26 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 9,080 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-011431 · form4.xml · derivative · entry 3 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,080 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| March 19, 2012 Filed Mar 20, 2012 21:26 UTC |
Loewald Thomas WSenior Vice President
|
SaleCommon Stock | 15,078 | $57.73 | $870,452.94 |
DisclosureSEC source: 0001127602-12-011431 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,736 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2012. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.63 to $57.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 19, 2012 Filed Mar 20, 2012 21:26 UTC |
Loewald Thomas WSenior Vice President
|
Exercise / conversionCommon Stock | 9,080 | $43.37 | $393,799.60 |
DisclosureSEC source: 0001127602-12-011431 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · derivative · entry 8 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2012-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on May 17, 2006, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc.. Read SEC document |
| March 09, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
SaleCommon Stock | 300 | $56.43 | $16,929.00 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 6 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,640 Read SEC document |
| March 09, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
SaleCommon Stock | 756 | $56.42 | $42,653.52 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 5 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,940 Read SEC document |
| March 09, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
SaleCommon Stock | 2,694 | $56.41 | $151,968.54 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 4 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,696 Read SEC document |
| March 09, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
Exercise / conversionCommon Stock | 3,750 | $26.53 | $99,487.50 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 3 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:14 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $34.86 | $0.00 |
DisclosureSEC source: 0001127602-12-010408 · form4.xml · derivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,000 shares Expires 2013-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on February 27, 2007, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc. Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:14 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 90,000 | $56.00 | $5,040,000.00 |
DisclosureSEC source: 0001127602-12-010408 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,334.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2012. Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:14 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 90,000 | $34.86 | $3,137,400.00 |
DisclosureSEC source: 0001127602-12-010408 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,334.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,750 | $0.00 Strike: $26.53 | $0.00 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · derivative · entry 7 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2012-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on May 17, 2006, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc.. Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
SaleCommon Stock | 3,750 | $56.05 | $210,187.50 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 2 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,640 Read SEC document |
| March 08, 2012 Filed Mar 12, 2012 21:16 UTC |
PORTER MICHAEL EDirector
|
Exercise / conversionCommon Stock | 3,750 | $26.53 | $99,487.50 |
DisclosureSEC source: 0001127602-12-010409 · form4.xml · nonDerivative · entry 1 PORTER MICHAEL E · CIK 0001108494 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:05 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $34.86 | $0.00 |
DisclosureSEC source: 0001127602-12-009815 · form4.xml · derivative · entry 4 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 100,000 shares Expires 2013-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option originally was to have vested in three equal annual installments beginning on February 27, 2007, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:05 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
SaleCommon Stock | 100,000 | $56.51 | $5,651,000.00 |
DisclosureSEC source: 0001127602-12-009815 · form4.xml · nonDerivative · entry 3 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,334.53 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2012. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.28 to $57.10, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:05 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 100,000 | $34.86 | $3,486,000.00 |
DisclosureSEC source: 0001127602-12-009815 · form4.xml · nonDerivative · entry 2 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,334.53 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:08 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Tax withholdingCommon Stock | 726 | $56.56 | $41,062.56 |
DisclosureSEC source: 0001127602-12-009821 · form4.xml · nonDerivative · entry 2 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,833 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:09 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 148 | $56.56 | $8,370.88 |
DisclosureSEC source: 0001127602-12-009822 · form4.xml · nonDerivative · entry 2 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,104 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:11 UTC |
Loewald Thomas WSenior Vice President
|
Tax withholdingCommon Stock | 466 | $56.56 | $26,356.96 |
DisclosureSEC source: 0001127602-12-009823 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,734 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:14 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 1,571 | $56.56 | $88,855.76 |
DisclosureSEC source: 0001127602-12-009825 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,899 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:15 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 1,573 | $56.56 | $88,968.88 |
DisclosureSEC source: 0001127602-12-009829 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,293 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:18 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 1,516 | $56.56 | $85,744.96 |
DisclosureSEC source: 0001127602-12-009834 · form4.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,224 Read SEC document |
| March 05, 2012 Filed Mar 7, 2012 00:21 UTC |
Thomson Andrew JSenior Vice President
|
Tax withholdingCommon Stock | 204 | $56.56 | $11,538.24 |
DisclosureSEC source: 0001127602-12-009839 · form4.xml · nonDerivative · entry 2 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,982 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:05 UTC |
CASPER MARC NDirector · Chief Executive Officer
|
GrantCommon Stock | 145,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009815 · form4.xml · nonDerivative · entry 1 CASPER MARC N · CIK 0001216055 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,334.53 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:08 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
GrantCommon Stock | 14,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009821 · form4.xml · nonDerivative · entry 1 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,559 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:09 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 7,650 | $0.00 Strike: $57.25 | $0.00 |
DisclosureSEC source: 0001127602-12-009822 · form4.xml · derivative · entry 4 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,650 Underlying: Common Stock · 7,650 shares Expires 2019-03-02 F1 · derivative.exercise_date: The option vests in four equal annual installments beginning on March 2, 2013. Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:09 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
GrantCommon Stock | 2,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009822 · form4.xml · nonDerivative · entry 1 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,252 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:11 UTC |
Loewald Thomas WSenior Vice President
|
GrantCommon Stock | 21,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009823 · form4.xml · nonDerivative · entry 1 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,200 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:14 UTC |
Malus Alan JExecutive Vice President
|
GrantCommon Stock | 43,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009825 · form4.xml · nonDerivative · entry 1 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,470 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:15 UTC |
Pesicka Edward ASenior Vice President
|
GrantCommon Stock | 40,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009829 · form4.xml · nonDerivative · entry 1 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,866 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:18 UTC |
WILVER PETER MSr. VP & CFO
|
GrantCommon Stock | 32,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009834 · form4.xml · nonDerivative · entry 1 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,740 Read SEC document |
| March 02, 2012 Filed Mar 7, 2012 00:21 UTC |
Thomson Andrew JSenior Vice President
|
GrantCommon Stock | 21,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-009839 · form4.xml · nonDerivative · entry 1 Thomson Andrew J · CIK 0001542508 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,186 Read SEC document |
| February 28, 2012 Filed Feb 28, 2012 22:33 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,440 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001127602-12-008466 · form4.xml · derivative · entry 6 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,360 Underlying: Common Stock · 15,440 shares Expires 2013-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested in five equal installments on November 9, 2007, 2008, 2009, 2010, and 2011. Read SEC document |
| February 28, 2012 Filed Feb 28, 2012 22:33 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
SaleCommon Stock | 15,440 | $57.00 | $880,080.00 |
DisclosureSEC source: 0001127602-12-008466 · form4.xml · nonDerivative · entry 4 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,909 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2011, and amended on October 28, 2011. Read SEC document |
| February 28, 2012 Filed Feb 28, 2012 22:33 UTC |
HOOGASIAN SETH HSr. VP, Gen. Counsel & Sec.
|
Exercise / conversionCommon Stock | 15,440 | $43.37 | $669,632.80 |
DisclosureSEC source: 0001127602-12-008466 · form4.xml · nonDerivative · entry 3 HOOGASIAN SETH H · CIK 0001216070 · Sr. VP, Gen. Counsel & Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,349 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:22 UTC |
Loewald Thomas WSenior Vice President
|
Tax withholdingCommon Stock | 772 | $56.66 | $43,741.52 |
DisclosureSEC source: 0001127602-12-008454 · form4.xml · nonDerivative · entry 2 Loewald Thomas W · CIK 0001538555 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,350 Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:23 UTC |
WILVER PETER MSr. VP & CFO
|
Tax withholdingCommon Stock | 2,169 | $56.66 | $122,895.54 |
DisclosureSEC source: 0001127602-12-008455 · form4.xml · nonDerivative · entry 2 WILVER PETER M · CIK 0001234537 · Sr. VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,590 Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:26 UTC |
Pesicka Edward ASenior Vice President
|
Tax withholdingCommon Stock | 1,835 | $56.66 | $103,971.10 |
DisclosureSEC source: 0001127602-12-008456 · form4.xml · nonDerivative · entry 2 Pesicka Edward A · CIK 0001439487 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,716 Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:28 UTC |
Malus Alan JExecutive Vice President
|
Tax withholdingCommon Stock | 1,835 | $56.66 | $103,971.10 |
DisclosureSEC source: 0001127602-12-008457 · form4.xml · nonDerivative · entry 2 Malus Alan J · CIK 0001380163 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,670 Read SEC document |
| February 26, 2012 Filed Feb 28, 2012 22:29 UTC |
HORNSTRA PETER EVP & Chief Accounting Officer
|
Tax withholdingCommon Stock | 201 | $56.66 | $11,388.66 |
DisclosureSEC source: 0001127602-12-008460 · form4.xml · nonDerivative · entry 2 HORNSTRA PETER E · CIK 0001216071 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,152 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.